Harnessing the immune system in the battle against breast cancer
Breast cancer is the most prevalent malignancy in women and the second most common cause of cancer-related death worldwide. Despite major innovations in early detection and advanced therapeutics, up to 30% of women with nodenegative breast cancer and 70% of women with node-positive breast cancer wil...
Saved in:
Main Authors: | Elizabeth S Nakasone (Author), Sara A Hurvitz (Author), Kelly E McCann (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the use of PARP inhibitor therapy for breast cancer
by: Kelly E McCann, et al.
Published: (2018) -
Awareness is the first step in battle against breast cancer
Published: (2012) - Awareness is the first step in battle against breast cancer
-
Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery
by: Ninh M. La-Beck, et al.
Published: (2019) -
Harnessing Bacterial Extracellular Vesicle Immune Effects for Cancer Therapy
by: Irem Karaman, et al.
Published: (2024)